In addition, twenty of these RBPs had significantly higher expression levels in breast cancer compared to NAT in TCGA and GTEx datasets (Figure 4B) and a high expression of RBPs in breast cancer also correlated with a high expression of TCNEs (Figure 4C). The gene discussed is BRD2; the disease is breast carcinoma.